Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice

Addiction Biology

Volumn 12, Issue 1, 2007, Pages 35-50

  Heidbreder, Christian A ^a,d   Andreoli, Michela ^a   Marcon, Cristina ^a   Hutcheson, Daniel M ^a   Gardner, Eliot L ^b   Ashby Jr , Charles R ^c  

^a Centre of Excellence for Drug Discovery in Psychiatry   (Italy)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c ST JOHN'S UNIVERSITY   (United States)

^d GSK   (Italy)

Author keywords

Acamprosate; Alcohol self administration; Baclofen; Dopamine D3 receptors; Naltrexone; SB 277011A

Indexed keywords

ACAMPROSATE; ALCOHOL; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; NALTREXONE;

ACUTE DRUG ADMINISTRATION; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DRUG EFFECT; DRUG SELECTIVITY; DRUG SELF ADMINISTRATION; INSTRUMENTAL CONDITIONING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RELAPSE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ALCOHOL DETERRENTS; ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; NALTREXONE; NITRILES; RECEPTORS, DOPAMINE D3; TAURINE; TETRAHYDROISOQUINOLINES;

EID: 33947145759     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2007.00051.x     Document Type: Article

References (123)

1. Altshuler HL, Phillips PE, Feinhandler DA (1980) Alteration of alcohol self-administration by naltrexone. Life Sci 26:679-688.
2. 3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior. Neuropsychopharmacology 28:1272-1280.
3. 3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats. Synapse 48:154-156.
4. 3 receptor antagonists (+)-S 14297, nafadotride, GR 103 691 and U 99194. J Pharmacol Exp Ther 287:187-197.
5. Bachteler D, Economidou D, Danysz W, Ciccocioppo R, Spanagel R (2005) The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat. Neuropsychopharmacology 30:1104-1110.
6. Bachtell RK, Wang YM, Freeman P, Risinger FO, Ryabinin AE (1999) Alcohol drinking produces brain region-selective changes in expression of inducible transcription factors. Brain Res 847:157-165.
7. Bienkowski P, Kostowski W, Koros E (1999) The role of drug-paired stimuli in extinction and reinstatement of ethanol-seeking behaviour in the rat. Eur J Pharmacol 374:315-319.
8. Bohn MJ, Kranzler HR, Beazoglou D, Staehler BA (1994) Naltrexone and brief counseling to reduce heavy drinking. Am J Addict 3:91-99.
9. Boismare F, Daoust M, Moore N, Saligaut C, Lhuintre JP, Chretien P, Durlach J (1984) A homotaurine derivative reduces the voluntary intake of alcohol by rats: are cerebral GABA receptors involved? Pharmacol Biochem Behav 21:787-789.
10. 2 receptor mRNA. Brain Res 564:203-219.
11. Boyce JM, Risinger FO (2000) Enhancement of alcohol reward by dopamine D3 receptor blockade. Brain Res 880:202-206.
12. Boyce-Rustay JM, Risinger FO (2003) Dopamine D3 receptor knockout mice and the motivational effects of ethanol. Pharmacol Biochem Behav 75:373-379.
13. Brown SA, Vik PW, Patterson TL, Grant I, Schuckit MA (1995) Stress, vulnerability and adult alcohol relapse. J Stud Alcohol 56:538-545.
14. 2 receptors. J Med Chem 46:3822-3839.
15. Cervo L, Cocco A, Petrella C, Heidbreder CA (2006) Selective antagonism at dopamine D 3 receptors attenuates cocaine-seeking behaviour in the rat. Int J Neuropsychopharmacol 23:1-15 [Electronic publication ahead of print].
16. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156:11-18.
17. Ciccocioppo R, Martin-Fardon R, Weiss F (2002) Effect of selective blockade of mu (1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology 27:391-399.
18. Cooper ML, Russell M, Skinner JB, Frone MR, Mudar P (1992) Stress and alcohol use: moderating effects of gender, coping, and alcohol expectancies. J Abnorm Psychol 101:139-152.
19. Cowen MS, Adams C, Kraehenbuehl T, Vengeliene V, Lawrence AJ (2005) The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system. Addict Biol 10:233-242.
20. Cunningham CL, Howard MA, Gill SJ, Rubinstein M, Low MJ, Grandy DK (2000) Ethanol-conditioned place preference is reduced in dopamine D2 receptor-deficient mice. Pharmacol Biochem Behav 67:693-699.
21. Dahchour A, De Witte P, Bolo N, Nedelec JF, Muzet M, Durbin P, Macher JP (1998) Central effects of acamprosate: part I. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in alcohol withdrawn rats. Psychiatry Res 82:107-114.
22. De Witte P (1984) Naloxone reduces alcohol intake in a free-choice procedure even when both drinking bottles contain saccharin sodium or quinine substances. Neuropsychobiology 12:73-77.
23. Di Ciano P, Blaha CD, Phillips AG (1998) Conditioned changes in dopamine oxidation currents in the nucleus accumbens of rats by stimuli paired with self-administration or yoked administration of d-amphetamine. Eur J Neurosci 10:1121-1127.
24. 3 receptor in the rat brain. Neuroscience 65:731-745.
25. 3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 20:8677-8684.
26. Elmer GI, Meisch RA, George FR (1986) Oral alcohol reinforced behavior in inbred mice. Pharmacol Biochem Behav 24:1417-1421.
27. Elmer GI, Meisch RA, George FR (1987a) Differential concentration- response curves for oral alcohol self-administration in C57BL/6J and BALB/cJ mice. Alcohol 4:63-68.
28. Elmer GI, Meisch RA, George FR (1987b) Mouse strain differences in operant self-administration of alcohol. Behav Genet 17:439-451.
29. Elmer GI, Meisch RA, Goldberg SR, George FR (1988) Fixed-ratio schedules of oral alcohol self-administration in inbred mouse strains. Psychopharmacology (Berl) 96:431-436.
30. Erb S, Salmaso N, Rodaros D, Stewart J (2001) A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 158:360-365.
31. Froehlich JC, Harts J, Lumeng L, Li T-K (1990) Naloxone attenuates voluntary alcohol intake in rats selectively bred for high alcohol preference. Pharmacol Biochem Behav 35:385-390.
32. Gallistel CR, Davis AJ (1983) Affinity for the dopamine D2 receptor predicts neuroleptic potency in blocking the reinforcing effect of MFB stimulation. Pharmacol Biochem Behav 19:867-872.
33. Gewiss M, Heidbreder C, Opsomer L, Durbin P, De Witte P (1991) Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of alcohol vapours. Alcohol Alcohol 26:129-137.
34. 3 receptors. Synapse 57:17-28.
35. Harmer CJ, Phillips GD (1999) Enhanced dopamine efflux in the amygdala by a predictive, but not a non-predictive, stimulus: facilitation by prior repeated d-amphetamine. Neuroscience 90:119-130.
36. 3 receptors in the addictive properties of ethanol. Drugs Today (Barc) 40:355-365.
37. 3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Rev 49:77-105.
38. Heidbreder CA, Groenewegen HJ (2003) The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev 27:555-579.
39. Herz A (1997) Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berl) 129:99-111.
40. Heyser CJ, Moc K, Koob GF (2003) Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats. Neuropsychopharmacology 28:1463-1471.
41. Heyser CJ, Schulteis G, Durbin P, Koob GF (1998) Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18:125-133.
42. Hodgson R, Rankin H, Stockwell T (1979) Alcohol dependence and the priming effect. Behav Res Ther 17:379-387.
43. Hore BD (1971) Factors in alcoholic relapse. Br J Addict Alcohol Other Drugs 66:89-96.
44. Hubbell CL, Czirr SA, Hunter GA, Beaman CM, LeCann NC, Reid LD (1986) Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol 3:39-54.
45. Hunt WA, Barnett LW, Branch LG (1971) Relapse rates in addiction programs. J Clin Psychol 27:455-456.
46. Hyytia P (1993) Involvement of mu opioid receptors in alcohol drinking by alcohol preferring AA rats. Pharmacol Biochem Behav 45:697-701.
47. Hyytia P, Sinclair JD (1993) Responding for oral ethanol after naloxone treatment by alcohol-preferring AA rats. Alcoholism: Clinical and Experimental Research 17:631-636.
48. Ito R, Dalley JW, Howes SR, Robbins TW, Everitt BJ (2000) Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J Neurosci 20:7489-7495.
49. Joyce JN, Millan MJ (2005) Dopamine D3 receptor antagonists as therapeutic agents. Drug Discov Today 10:917-925.
50. Katner SN, Magalong JG, Weiss F (1999) Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat. Neuropsychopharmacology 20:471-479.
51. Katner SN, Weiss F (1999) Ethanol-associated olfactory stimuli reinstate ethanol-seeking behavior after extinction and modify extracellular dopamine levels in the nucleus accumbens. Alcohol Clin Exp Res 23:1751-1760.
52. Kienast T, Heinz A (2006) Dopamine and the diseased brain. CNS Neurol Disord Drug Targets 5:109-131.
53. Kirk RE (1982) Experimental Design: Procedures for the Behavioral Sciences, 2nd edn. Belmont, CA: Brooks/Cole Publishing Co.
54. Krishnan-Sarin S, Portoghese PS, Li T-K, Froehlich JC (1995) The delta2 opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol Biochem Behav 52:153-159.
55. Krishnan-Sarin S, Wand GS, Li X-W, Portoghese PS, Froehlich JC (1998) Effect of mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking. Pharmacol Biochem Behav 59:627-635.
56. Laszy J, Laszlovszky I, Gyertyán I (2005) Dopamine D3 receptor antagonists improve the learning performance of memory-impaired rats. Psychopharmacology (Berl) 179:567-575.
57. Le Magnen J, Tran G, Durlach J (1987) Lack of effects of Caacetyl homotaurinate on chronic and acute toxicities of alcohol in rats. Alcohol 4:103-108.
58. Lê AD, Poulos CX, Harding S, Watchus J, Juzytsch W, Shaham Y (1999) Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress. Neuropsychopharmacology 21:435-444.
59. Lê AD, Poulos CX, Quan B, Chou S (1993) The effects of selective blockade of delta and mu opiate receptors on alcohol consumption by C57Bl/6 mice in a restricted access paradigm. Brain Res 630:330-332.
60. Lê AD, Quan B, Juzytch W, Fletcher PJ, Joharchi N, Shaham Y (1998) Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology (Berl) 135:169-174.
61. Lê A, Shaham Y (2002) Neurobiology of relapse to alcohol in rats. Pharmacol Ther 94:137-156.
62. Ledford CC, Fuchs RA, See RE (2003) Potentiated reinstatement of cocaine-seeking behavior following D-amphetamine infusion into the basolateral amygdala. Neuropsychopharmacology 28:1721-1729.
63. Leri F, Flores J, Rodaros D, Stewart J (2002) Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci 22:5713-5718.
64. Littleton J (1995) Acamprosate in alcohol dependence: how does it work? Addiction 90:1179-1188.
65. Ludwig AM, Wikler A, Stark LH (1974) The first drink: psychobiological aspects of craving. Arch Gen Psychiatry 30:539-547.
66. 3 receptor antagonist. J Med Chem 46:4952-4964.
67. Mann K, Lehert P, Morgan MY (2004) The efficiacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res 28:51-63.
68. Marfaing-Jallat P, Miceli D, Le Magnen J (1983) Decrease in ethanol consumption by naloxone in naive and dependent rats. Pharmacol Biochem Behav 18:537-539.
69. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, Evrard A, Cazala P, Cormier A, Mameli-Engvall M, Dufour N, Cloez-Tayarani I, Bemelmans AP, Mallet J, Gardier AM, David V, Faure P, Granon S, Changeux JP (2005) Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436:103-107.
70. Middaugh LD, Kelley BM (1999) Operant alcohol reward in C57BL/6 mice: influence of gender and procedural variables. Alcohol 17:185-194.
71. Miliaressis E, Malette J, Coulombe D (1986a) The effects of pimozide on the reinforcing efficacy of central gray stimulation in the rat. Behav Brain Res 21:95-100.
72. Miliaressis E, Rompre PP, Laviolette P, Philippe L, Coulombe D (1986b) The curve-shift paradigm in self-administration. Physiol Behav 37:85-93.
73. Miller L (1991) Predicting relapse and recovery in alcoholism and addiction: neuropsychology, personality, and cognitive style. J Subst Abuse Treat 8:277-291.
74. Monti PM, Rohsenow DJ, Rubonis AV, Niaura RS, Sirota AD, Colby SM, Abrams DB (1993) Alcohol cue reactivity: effects of detoxification and extended exposure. J Stud Alcohol 54:235-245.
75. 2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci USA 91:11271-11275.
76. Narita M, Soma M, Tamaki H, Narita M, Suzuki T (2002) Intensification of the development of alcohol dependence in mice lacking dopamine D (3) receptor. Neurosci Lett 324:129-132.
77. Newman AH, Grundt P, Nader MA (2005) Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. J Med Chem 48:3663-3679.
78. O'Brien CP (1997) Progress in the science of addiction. Am J Psychiatry 154:1195-1197.
79. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsavielle B (1992) Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 49:881-887.
80. Paille FM, Guelfi JD, Perkins AC, Royer RJ, Steru L, Parot P (1995) Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcohol 30:239-247.
81. 3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Int J Neuropsychopharmacol 9:585-602.
82. Phillips TJ, Brown KJ, Burkhart-Kasch S, Wenger CD, Kelly MA, Rubinstein M, Grandy DK, Low MJ (1998) Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. Nat Neurosci 1:610-615.
83. Putzke J, Spanagel R, Toelle TR, Ziegelgansberger W (1996) The novel anti-craving drug acamprosate alters the expression of NMDA R1 splice variant mRNAs in the rat brain. J Neural Transm 103:45-46.
84. 3 receptor antagonist, SB-277011-A. J Pharmacol Exp Ther 294:1154-1165.
85. Reid LD, Hunter GA (1984) Morphine and naloxone modulate intake of ethanol. Alcohol 1:33-37.
86. Risinger FO, Brown MM, Oakes RA, Love JA (1999) Effects of haloperidol and SCH-23390 on alcohol-induced conditioned taste aversion. Alcohol 18:139-145.
87. Rossetti Z, Carboni S (1995) Alcohol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur J Pharmacol 283:177-183.
88. Samson HH, Doyle TF (1985) Oral alcohol self-administration in the rat: effect of naloxone. Pharmacol Biochem Behav 22:91-99.
89. Sandi C, Borrell J, Guaza C (1988) Naloxone decreases ethanol consumption within a free choice paradigm in rats. Pharmacol Biochem Behav 29:39-43.
90. Sass H, Soyka M, Mann K, Zieglgansberger W (1996) Relapse prevention by acamprosate: results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry 53:673-680.
91. Schroff KC, Cowen MS, Koch S, Spanagel R (2004) Strain-specific responses of inbred mice to ethanol following food shortage. Addict Biol 9:265-271.
92. Schwarz AJ, Gozzi A, Reese T, Bertani S, Crestan V, Hagan JJ, Heidbreder C, Bifone A (2004) Selective dopamine D3 receptor antagonist SB-277011-A potentiates phMRI response to acute amphetamine challenge in the rat brain. Synapse 54:1-10.
93. 3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Brain Res Mol Brain Res 45:335-339.
94. Sinclair JD, Li T-K (1989) Long and short alcohol deprivation: effects on AA and P alcohol-preferring rats. Alcohol 6:505-509.
95. Spanagel R, Holter SM (2000) Pharmacological validation of a new animal model of alcoholism. J Neural Transm 107:669-680.
96. Spanagel R, Holter SM, Allingham K, Landgraf R, Zieglgaensberger W (1996) Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305:39-44.
97. Spanagel R, Pendyala G, Abarca C, Zghoul T, Sanchis-Segura C, Magnone MC, Lascorz J, Depner M, Holzberg D, Soyka M, Schreiber S, Matsuda F, Lathrop M, Schumann G, Albrecht U (2005) The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med 11:35-42.
98. Staiger PK, White JM (1991) Cue reactivity in alcohol abusers: stimulus specificity and extinction of the responses. Addict Behav 16:211-221.
99. 3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 16:6100-6106.
100. Stellar JR, Kelly A, Corbett D (1983) Effects of peripheral and central dopamine blockade on lateral hypothalamic stimulation reward: evidence for both reward and motor deficits. Pharmacol Biochem Behav 18:433-442.
101. 3 receptor antagonist with high oral bioavailability and CNS penetration in the rat. J Med Chem 43:1878-1885.
102. Stewart J (2000) Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci 25:125-136.
103. Swift RM, Whelihan W, Kuznetsov O, Buongiorno G, Hsuing H (1994) Naltrexone-induced alterations in human alcohol intoxication. Am J Psychiatry 151:1463-1467.
104. Tamminga CA (1999) The anterior cingulate and response conflict. Am J Psychiatry 156:1849.
105. Thanos PK, Katana JM, Ashby CR Jr, Michaelides M, Gardner EL, Heidbreder CA, Volkow ND (2005) The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats. Pharmacol Biochem Behav 81:190-197.
106. Vengeliene V, Leonardi-Essmann F, Perreau-Lenz S, Gebicke-Haerter P, Drescher K, Gross G, Spanagel R (2006) The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse. FASEB 20:2223-2233.
107. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880.
108. Volpicelli JR, Davis MA, Olgin JE (1986) Naltrexone blocks the post-shock increase of alcohol consumption. Life Sci 38:841-847.
109. Vorel SR, Ashby CR Jr, Paul M, Liu X, Hayes R, Hagan JJ, Middlemiss DN, Stemp G, Gardner EL (2002) Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 22:9595-9603.
110. Vorel SR, Liu X, Hayes RJ, Spector JA, Gardner EL (2001) Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science 292:1175-1178.
111. 3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour. J Neural Transm Gen Sect 98:39-55.
112. Weiss F (2005) Neurobiology of craving, conditioned reward and relapse. Curr Opin Pharmacol 5:9-19.
113. Weiss F, Maldonado-Vlaar CS, Parsons LH, Kerr TM, Smith DL, Ben-Shahar O (2000) Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proc Natl Acad Sci USA 97:4321-4326.
114. Weiss F, Mitchiner M, Bloom FE, Koob GF (1990) Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide. Psychopharmacology (Berl) 101:178-186.
115. White JM, Staiger PK (1991) Response to alcohol cues as a function of consumption level. Drug Alcohol Depend 27:191-195.
116. Whitelaw RB, Markou A, Robbins TW, Everitt BJ (1996) Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology (Berl) 127:213-224.
117. Whitworth AB, Fischer F, Lesch OM, Nimmerrichter A, Oberbauer H, Platz T, Potgieter A, Walter H, Fleischhacker WW (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 347:1438-1442.
118. Wolffgramm J, Heyne A (1995) From controlled intake to loss of control: the irreversible development of drug addiction in the rat. Behav Brain Res 70:77-94.
119. Wyvell CL, Berridge KC (2000) Intra-accumbens amphetamine increases the conditioned incentive salience of sucrose reward: enhancement of reward 'wanting' without enhanced 'liking' or response reinforcement. J Neurosci 20:8122-8130.
120. 3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats. Psychopharmacology (Berl) 176:57-65.
121. 3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost- variable-payoff fixed-ratio cocaine self-administration in rats. Eur J Neurosci 21:3427-3438.
122. Xi ZX, Newman AH, Gilbert JG, Pak AC, Peng XQ, Ashby CR Jr, Gitajn L, Gardner EL (2006) The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology 31:1393-1405.
123. Xu M, Koeltzow TE, Cooper DC, Tonegawa S, White FJ (1999) Dopamine D3 receptor mutant mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists. Synapse 31:210-215.